Boehringer Ingelheim, a leading biopharmaceutical company, has teamed up with the Emirates Thoracic Society (ETS) and social ...

Rishi Sunak has joined Prostate Cancer Research as an ambassador to champion the charity’s campaign for a national screening ...

The findings of the Stratified Medicine Paediatrics (SMPaeds1) programme, published in the journal Cancer Discovery, ...

BC Platforms has announced that it has appointed Mukhtar Ahmed as its new Chief Executive Officer (CEO). Ahmed brings over ...

The US Food and Drug Administration (FDA) has approved Deciphera Pharmaceuticals’ Romvimza (vimseltinib) to treat adults with ...

A new UK study has highlighted the critical role of GP data in understanding atrial fibrillation (AF), the most common form ...

The University of Bath has received a £3.5 million Wellcome grant to study cognitive decline and premature brain ageing in ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

NHS England has launched its first-ever breast cancer awareness campaign aimed at highlighting the benefits of screening for ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

After two years of treatment with bimekizumab, 53.1% of patients experienced mild disease compared to none at baseline.

Amlenetug received Orphan Drug Designation (ODD) from the US FDA in April 2024, the EMA in May 2021 and SAKIGAKE designation ...